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Adverse reactions to drugs: Should we have formal 
programs for reporting them? 
Edward A. Carr, Jr., M.D. Ann Arbor, Mich. 
Departments of Pharmacology and Internal Medicine, University of Michigan School of Medicine 
The strong right arm of therapeutics has 
made such benefits available to patients in 
recent years that few would wish to re-
turn to the past. Those who decry treat-
ment with modern drugs should go to some 
area of the world where these drugs are 
not available and see how it is to live (or 
more often die) without them. But our pa-
tients still run the risk of falling into an-
other sinister grip-serious adverse reac-
tions to the drugs we use. There has been 
a tendency for many physicians to accept 
too eagerly the immediate benefits of mod-
ern drugs, while a sour minority has 
stressed almost exclusively their adverse 
effects. It is time the right hand knew what 
the left hand is doing, and vice versa. 
In some medical centers, a formal pro-
,gram for the detection and reporting of ad-
verse reactions to drugs has been instituted. 
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These programs are designed to collect de-
tailed information on every adverse reac-
tion that occurs within the medical center 
and make this information available to all 
physicians associated with the center. The 
question is: Do such programs really ac-
complish any good? If they do, what fac-
tors contribute most to their success? 
The chief value of such programs is not 
that they "give us an over-all picture," 
"provide a broad survey of the problem," 
and so forth. In many aspects of sociology 
and science during the past ten years, we 
have been "given over-all pictures" and 
"provided with broad surveys" to such a 
point that no one can digest the data. The 
chief value of a program for reporting drug 
reactions is that it makes everyone involved 
alert to the dangers of modern therapy and 
this alertness is based on "close to home" 
occurrences that really impress themselves 
on the minds of those associated with the 
medical center in question. Therefore, 
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prompt and practical solutions to some of 
the problems discovered can often be 
worked out by the staff. The reports, if pre-
sented at reasonable intervals to the entire 
staff, bring to the attention of each physi-
cian new dangers that have arisen with 
new remedies. Thus, when the administra-
tion of a certain intravenous vitamin K 
preparation was found to be followed by 
a severe anaphylactoid reaction in two pa-
tients, this information was immediately 
made available to the Pharmacy and Ther-
apy Committee, the use of the preparation 
was immediately discontinued until a 
method for its safe administration could be 
worked out, and the staff was notified. In 
the field of drug reactions, as in contagious 
diseases, it is often desirable for the physi-
cian in any given area to know "what is go-
ing around this year." Another value of 
such programs is their "seed value"; young 
physicians taking part in them are likely to 
develop an interest in clinical pharmacol-
ogy and will perhaps institute similar pro-
grams in other hospitals and medical cen-
ters in future years. 
There are two major disadvantages to 
such programs. First, there is already a 
huge superstructure of committees, reports, 
administrative make-work, etc., piled upon 
the practicing physiCian. Like his brother, 
the active scientific investigator, he already 
spends far too much time with such non-
sense. Therefore, no additional program in-
volving forms, reports, etc., can be toler-
ated unless it makes a very real contribu-
tion to medicine. Second, the constant col-
lection and reporting of adverse reactions 
to drugs is likely to have the same effect 
upon the local attorneys as a brisk hemor-
rhage into the water has upon nearby 
sharks. 
The first objection is more easily met 
than then second. A program for reporting 
adverse drug reactions probably can be 
carried out without cumbersome paper 
work and probably contributes enough to 
the safety of the patient to justify it. The 
second objection is a more serious one. On 
one occasion, I gave a talk on drug reac-
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tions before a county medical society and 
was surprised to find that my appearance 
and talk were given advance publicity 
which scrupulously omitted the title of the 
talk. I could easily understand why my ap-
pearance in town would not necessarily de-
serve any type of advertisement at all, but 
I could not understand why, once the ar-
rangement committee had decided upon 
advance publicity, the title of the talk 
should be omitted. Upon inquiry, I was in-
formed that the subject of adverse reac-
tions to drugs had made everyone so jittery 
and sensitive that it was deemed best to 
keep the phrase "adverse reactions to 
drugs" entirely out of the local newspaper. 
This may represent an extreme case, but it 
does show the general reaction engendered 
by lawyers in the minds of most doctors. 
This state of affairs will continue until such 
time as the courts finally begin to dispense 
more even justice in professional liability 
suits. If this day ever dawns, then programs 
for reporting adverse drug reactions will 
be most helpful. They will serve to protect 
the physician who exercises reasonable cau-
tion, in that the courts will give directed 
verdicts in favor of physicians who can 
demonstrate that they did show reasonable 
caution. Such programs will serve to re-
strict liability to those who are deservedly 
liable. If a series of reasonable standard 
steps to decrease the incidence of drug re-
actions is established, then the physician 
who takes these standard precautions de-
serves to be protected by the court just as 
much as the phYSician who ignores them 
deserves to be held liable. At the present 
time, of course, the legal philosophy is, "If 
you don't take precautions, you are, of 
course, liable; if you do take precautions, 
you are liable anyway." 
Thus, the development of programs for 
reporting adverse drug reactions in large 
medical centers and other hospitals seems 
to have more advantages than disadvant-
ages, although the last objection discussed 
does represent a most serious and poten-
tially fatal disadvantage. 
What are the factors that make such pro-
Volume 5 
Numbcr2 
grams feasible and successful? First, one 
must realize that it is a waste of time to 
pass out forms to the various wards of a 
hospital and ask that they be filled out 
whenever a drug reaction occurs. It is 
necessary to choose a "leg man," a physi-
cian who constantly makes the rounds of 
the hospital and regularly asks nurses, phy-
sicians, medical students, etc., about the 
occurrence of adverse reactions. Some sort 
of reward must be offered the man who 
takes on this burden. Surprisingly, com-
mittees often seem at a loss to devise a suit-
able reward. Over the last several thou-
sand years a considerable body of evidence 
has accumulated suggesting that money is 
considered a rather acceptable reward in 
many fields of endeavor. If a resident or 
junior visiting man is assigned this task, 
he must be someone who haunts the wards 
of the hospital constantly and the hospital 
must see that he is paid for his pains. 
Second, each report must be written on 
one standard form, not exceeding one page. 
The form in use at The University of Mich-
igan Hospital provides for recording the 
following information: the suspected com-
pound, disease under treatment, other per-
tinent conditions, trade name, composition, 
dosage form, manufacturer's lot number (if 
known), etc.; the patient's name, occupa-
tion, attending physician; a description of 
the reaction and the details of the dosage 
schedule (number of doses, total amount, 
date of first dose, time interval between 
last dose and onset of reaction, history of 
previous exposure, etc.), concurrent drug 
therapy; outcome and additional remarks. 
There should be a standard procedure 
to provide for immediate recording of sus-
pected cases of hypersensitivity on the 
front of the patient's chart. I know of one 
instance in which fatal penicillin anaphy-
laxis occurred after a patient had been 
transferred from one clinical service to an-
other, because the allergy to penicillin that 
had been discovered on the first service 
was buried in the progress notes of the pa-
tient's thick chart and was not seen by 
those on the second service who wished to 
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order penicillin for the patient. In another 
instance, a senior visiting man discovered 
that a patient was hypersensitive to aspirin 
and observed that no note had been made 
on the front of the patient's chart. He 
promptly called the house staff and medi-
cal students together in an adjoining room 
and pointed out the necessity of having 
such information on the front of the chart. 
While he was explaining this, a dose of 
aspirin was administered by a nurse on the 
ward. The patient died of the reaction. 
Reports should be made to the staff at 
regular intervals but it is probably not ad-
visable to monopolize every monthly staff 
meeting with such reports. Semiannual re-
ports with supplementary emergency re-
ports of serious individual problems, will 
keep the staff alert. There should, however, 
be an arrangement whereby the pharmacy 
can immediately stop all administration 
of a given agent within the hospital and 
immediately collect all outstanding sup-
plies from the wards, if an emergency 
seems to dictate this. Such extreme deci-
sions, should, of course, be rare. 
There is no compelling reason to restrict 
such programs to large medical centers. 
Smaller hospitals may not have the services 
of a resident to walk the wards daily but 
one of the younger men starting in practice 
may be glad to have an opportunity to put 
in an appearance at the hospital every day 
and go to each of the clinical units. Such 
an individual, particularly if he has had 
training in clinical pharmacology, will soon 
become the local authority on drug reac-
tions and may also be the logical man to 
assume organization and direction of the 
hospital's poison control center. 
The administration of such a program 
should be sharply separated from discipli-
nary action. Certainly, in the vast majority 
of cases, reactions to drugs are misfortunes 
that hardly call for disciplinary action 
against a member of the staff. On the rare 
occasion that may call for such action, it 
would be advisable for those concerned 
with the drug reaction program to disso-
ciate themselves from the judging, as they 
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are already the principal witnesses. Any 
disciplinary action, if indicated, should be 
carried out according to the regular proto-
col of the hospital staff. 
The matter of reporting reactions to any 
central bureau in Washington or elsewhere 
deserves thought. Provided the identity of 
patient and physician is strictly protected, 
such reporting may be useful in that it 
enables a collection of data from many 
centers to be made. Moreover, funds for 
paying for the program are available in cer-
tain instances. On the other hand, expe-
rience so far has suggested that the feed-
back from central bureaus is slow or non-
existent, and, to date, medical centers seem 
to learn most from the reports of reactions 
that they have collected themselves. As the 
new Food and Drug regulations require 
such reporting of reactions to investigative 
drugs, it is to be hoped that in the future 
a more effective method of centralized data 
collection and feedback to participating 
hospitals may be developed. 
Finally, after all this information about 
adverse reactions to drugs is presented to 
staff members, what can they do about the 
problems described, anyway? After the left 
hand has been introduced to the right 
hand, are they simply to wring each other? 
Not at all. For example, the staff may de-
cide that Drug A should be discontinued 
from hospital use entirely; fresh solutions 
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of Drug B can no longer be made up on 
the wards because contamination is too 
easy and all preparations will have to be 
made up in the pharmacy; Drug C is too 
valuable to discontinue but the prevalence 
of reactions to it suggests that phYSicians 
place it on their mental list of drugs re-
served for serious emergencies; Drug D is 
apparently causing trouble whenever it is 
given too rapidly intravenously and, there-
fore, it must be available only in dilute 
solutions; Drug E has been inculpated in 
a certain reaction but a review of the de-
tails suggests that the reaction was not due 
to E at all, and the drug is acquitted; Drug 
F causes a reaction that is usually preceded 
by a day or two of itching and if the staff 
is alert for this sign and discontinues the 
drug at once, the subsequent reaction will 
be much less severe, and so on. If the medi-
cal center has a large staff, time will be 
saved if the Pharmacy and Therapy Com-
mittee makes preliminary decisions. These 
can subsequently be presented to the whole 
staff for its approval. 
In summary, programs for reporting ad-
verse reactions to drugs are not free of ob-
jections but they should be instituted be-
cause they seem to do considerably more 
good than harm. If this seems too weak a 
reason, consider this: It is the same reason 
that justifies giving drugs in the first place. 
